Study Shows Trump-Touted Anti-Malarial Drug May Have High Death Risk in COVID-19 Patients
1 sourceUpdated May 22, 2020
A new study on the anti-malarial drug, hydroxychloroquine, suggests the use of the drug as coronavirus treatment may lead to high death risks for COVID-19 patients. The new medical study, published by The Lancet on…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup